跳至主要内容
临床试验/NL-OMON33297
NL-OMON33297已完成不适用

Computer-aided ultrasonography (HistoScanning) in men with untreated localised prostate cancer on active surveillance. - PCa HistoScanning and Active Surveillance

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 115 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
115

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Male patient aged >= 18 years.
  • Newly diagnosed patients participating in PRIAS or patients participating for 3 years.
  • PRIAS has the following inclusion criteria:
  • o Histologically proven adenocarcinoma of the prostate
  • o Patient should be fit for curative treatment
  • o PSA-level at diagnosis <= 10 ng/mL
  • o PSA density (PSA D) less than 0,2
  • o Clinical stage T1C or T2
  • o Appropriate biopsy sampling
  • o Gleason score 3+3=6 (or less)
  • o One or 2 biopsy cores invaded with prostate cancer
  • o Participants must be willing to attend the follow-up visits
  • Provides written Informed Consent and is willing and able to comply with protocol requirements.

排除标准

  • Incapable of understanding the language in which the information for the patient is given.
  • Patient who can not or do not want to be radiated or operated
  • Previously treated for prostate cancer

研究者

相似试验